Memphis Pharmaceutical to invite shareholders for rights issues

Updated 9/19/2024 11:56:00 AM
Memphis Pharmaceutical to invite shareholders for rights issues

Arab Finance: The Financial Regulatory Authority (FRA) has approved publishing the disclosure form submitted by Memphis Pharmaceutical and Chemical Industries’ board to invite senior shareholders to subscribe to the company’s remaining rights issue, as per a statement.

Thus, the company invites shareholders to subscribe to 1.065 million shares at a nominal value of EGP 10 per share.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

 

Related News